Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720338 · ClinicalTrials.gov registry record · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
A Phase 3 study of Pancreatectomy and Cyst of Pancreas, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 234
- Enrollment target
- 1
- Study location
NCT05720338 is a Phase 3 study of Pancreatectomy and Cyst of Pancreas that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 234 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05720338, a Phase 3 study of Pancreatectomy and Cyst of Pancreas, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 234 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drainage with respect to a composite post-operative complications of Grade B or C Postoperative pancreatic fistula (POPF), readmission, or organ space surgical site infection following a distal pancreatectomy.
Conditions Studied
Interventions
- DEVICE 19 French Blake Drain
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2027-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05720338
The ClinicalTrials.gov registry entry for NCT05720338 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pancreatectomy appearing as the primary indexed condition, and to 1 intervention - of which 19 French Blake Drain is the first listed.
NCT05720338 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05720338 about?
NCT05720338 is a clinical study titled "Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?". The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drai...
What is the current status of trial NCT05720338?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 234 participants. The study started on 2023-04-13. Estimated completion is 2027-07-31.
What conditions does trial NCT05720338 study?
This clinical trial studies the following conditions: Pancreatectomy, Cyst of Pancreas, Pancreas Neoplasm.
What interventions are being tested in trial NCT05720338?
The interventions under investigation include: 19 French Blake Drain (DEVICE).
Who is sponsoring clinical trial NCT05720338?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720338 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.